Pfizer Inc
NYSE:PFE
Pfizer Inc
Interest Income Expense
Pfizer Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pfizer Inc
NYSE:PFE
|
Interest Income Expense
$1.5B
|
CAGR 3-Years
130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Interest Income Expense
$212m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Interest Income Expense
-$676m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Interest Income Expense
-$953m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-10%
|
|
Zoetis Inc
NYSE:ZTS
|
Interest Income Expense
-$181m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-4%
|
|
Eli Lilly and Co
NYSE:LLY
|
Interest Income Expense
-$368m
|
CAGR 3-Years
-133%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-30%
|
See Also
What is Pfizer Inc's Interest Income Expense?
Interest Income Expense
1.5B
USD
Based on the financial report for Mar 31, 2024, Pfizer Inc's Interest Income Expense amounts to 1.5B USD.
What is Pfizer Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
130%
The average annual Interest Income Expense growth rates for Pfizer Inc have been 130% over the past three years .